orexin receptor antagonist
Showing 1 - 25 of 9,823
Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,
Recruiting
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Posttraumatic
- Suvorexant
- Placebo
-
San Francisco, California
- +1 more
Nov 10, 2022
Opioid Use Disorder, Stimulant Use Disorder Trial in Baltimore (Suvorexant (dual orexin receptor antagonist), Placebo)
Recruiting
- Opioid Use Disorder
- Stimulant Use Disorder
- Suvorexant (dual orexin receptor antagonist)
- Placebo
-
Baltimore, MarylandBehavioral Pharmacology Research Unit at the Johns Hopkins Bayvi
Dec 13, 2022
Shift-Work Related Sleep Disturbance Trial in San Francisco (Lemborexant, Placebo)
Recruiting
- Shift-Work Related Sleep Disturbance
- Lemborexant
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 19, 2022
Insomnia, Sleep Fragmentation, Sleep Initiation and Maintenance Disorders Trial in Boston, Bronx (Suvorexant 20 mg, Placebo oral
Recruiting
- Insomnia
- +3 more
- Suvorexant 20 mg
- Placebo oral tablet
-
Boston, Massachusetts
- +1 more
May 18, 2022
Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)
Recruiting
- Alcohol Use Disorder
- Suvorexant
- Placebo
-
Columbus, OhioThe Ohio State University
Dec 11, 2022
Insomnia, Dementia, Frontotemporal Dementia Trial (Lemborexant 5 MG)
Not yet recruiting
- Insomnia
- +2 more
- Lemborexant 5 MG
- (no location specified)
Oct 16, 2023
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)
Recruiting
- Safety Issues
- +2 more
- Proglumide
- Placebo
-
Washington, District of ColumbiaGeorgetown University
Dec 1, 2022
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Placebo
- Ondansetron Injection
-
Montréal, Quebec, CanadaHôpital Sacré-Coeur de Montréal
Aug 22, 2022
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
Alzheimer, Insomnia Disorder, Sleep Trial in Montpellier (drug, procedure, behavioral, other)
Not yet recruiting
- Alzheimer Disease
- +2 more
- Daridorexant 50 mg
- +7 more
-
Montpellier, FranceUniversity Hospital, Montpellier
Jun 20, 2023
PTSD Trial in San Francisco (CORT108297, Placebo)
Not yet recruiting
- PTSD
- CORT108297
- Placebo
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022
Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)
Recruiting
- Rotator Cuff Tendinitis
- Chronic Pain
- Ketalar
- NaCl 9%
-
Kristiansund, NorwayDepartment of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022
Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)
Not yet recruiting
- Renal Cell Carcinoma
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)
Not yet recruiting
- Depressive Disorder, Major
- Anxiety Disorder
- Nociceptin Receptor Antagonist
- Aversive stimuli
- (no location specified)
Nov 3, 2022
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Cardiovascular Diseases, Vascular Dilation Trial in Worcester (Ifetroban Sodium, Placebo)
Recruiting
- Cardiovascular Diseases
- Vascular Dilation
- Ifetroban Sodium
- Placebo
-
Worcester, MassachusettsUniversity of Massachusetts Medical School
Feb 16, 2022
Steatohepatitis, Nonalcoholic Trial in Shibin Al Kawm (Control group, Montelukast group)
Completed
- Steatohepatitis, Nonalcoholic
- Control group
- Montelukast group
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Medicine
Mar 15, 2022
Netosis During COVID-19, Under Treatment With
Active, not recruiting
- Covid19
-
Paris, France
- +1 more
Mar 30, 2022